|
Sisters Network Inc.: Posted on Monday, February 04, 2013 7:36 PM
In 2012 Sisters Network hosted its Annual National African American Breast Cancer Conference. The 13th annual conference was held in Houston, Texas, April 12-15. The conference provided an informative platform, designed specifically for AA BC survivors to broaden the scope of knowledge that addresses the breast cancer survivorship crisis affecting African American women across the nation. HOWEVER ..... In preparation for our 20 year anniversary celebration in 2014, Sisters Network® Inc. |
|
|
NCI: Posted on Monday, January 14, 2013 3:20 PM
Over the past several years, the conversation about cancer screening has started to change within the medical community. Be it breast, prostate, or ovarian cancer, the trend is to recommend less routine screening, not more. These recommendations are based on an emerging—if counterintuitive—understanding that more screening does not necessarily translate into fewer cancer deaths and that some screening may actually do more harm than good.Much of the confusion surrounding the benefits of screening comes from interpreting the statistics that are often used to describe the results of screening studies. |
|
|
NCI: Posted on Monday, January 14, 2013 3:16 PM
According to the latest national data, overall death rates from cancer declined from 2000 through 2009 in the United States, maintaining a trend seen since the early 1990s. Mortality fell for most cancer types, including the four most common types of cancer in the United States (lung, colon and rectum,breast, and prostate), although the trend varied by cancer type and across racial and ethnic groups.
The complete "Annual Report to the Nation on the Status of Cancer, 1975–2009" appeared January 7 in the |
|
|
Memoirs of Cancer Book: Posted on Wednesday, December 05, 2012 11:05 PM
https://www.facebook.com/video/video.php?v=10150635846921971
If you can't open this video go to the link above.
Cancer is finally cured in Canada but Big Pharma has no interest.Cancer is finally cured in Canada but Big Pharma has no interest. The fact that the international drug & medical industry have no interest is because the cure is really cheaper than a chocolate bar and it won't get them to gain any profits at all. Besides, if people had the cure so easily, how will these medical companies make money out of that? |
|
|
Pancreatic Cancer Action Network: Posted on Saturday, November 10, 2012 3:59 PM
The Pancreatic Cancer Action Network is pleased to share the positive results of a pivotal clinical trial in the treatment of pancreatic cancer that were announced today by Celgene Corporation (Celgene). Celgene conducted a phase III clinical trial with the intent to show that the combination of its chemotherapy drug, ABRAXANE®, with gemcitabine would improve overall survival in patients with untreated, metastatic pancreatic adenocarcinoma when compared with gemcitabine alone. Treatment with gemcitabine alone has been the standard of care for pancreatic cancer. |
|
|
NCI: Posted on Friday, October 19, 2012 4:39 PM
Nelfinavir, a drug used to treat people infected with HIV, appears to halt the growth of HER2-positive breast cancer cells. Researchers led by Dr. Joong Sup Shim of the Johns Hopkins School of Medicine showed that, in the laboratory, doses of nelfinavir used to safely treat people infected with HIV inhibited the growth of drug-resistant HER2-positive breast cancer cells. The study appeared October 5 in theJournal of the National Cancer Institute.
Although several drugs are approved to treat HER2-positive breast cancers, tumors often develop |
|
|
ACS: Posted on Friday, October 12, 2012 1:18 PM
A recent study by American Cancer Society grantee Annette E. Maxwell, DrPH, from the University of California, Los Angeles, found that small, community-based multi-component interventions significantly increased colon cancer screening among Filipino Americans.
|
|
|
Memoirs of Cancer/ ACS: Posted on Friday, October 12, 2012 12:38 PM
New program developed called Esperanza y Vida (Hope and Life), is created by Deborah Erwin, PhD. This is a community-based program designed to increase breast and cervical cancer screenings among Latina women. Read more on our new page Recent Developments In Cancer Research Here.
To learn more on breast cancer click here. |
|
|
NCI/MEMOIRS OF CANCER: Posted on Thursday, October 11, 2012 12:36 PM
 Using a combination of analytical tools, investigators with The Cancer Genome Atlas(TCGA) Research Network have completed a molecular study of breast tumors from 825 women. The results, recently reported in Nature, confirm the existence of four major subtypes of breast cancer and add new details about the biological changes underlying these diseases.The researchers used up to six different technologies to characterize subsets of the tumors. In addition to sequencing DNA and |
|
|
NCI: Posted on Thursday, October 11, 2012 12:22 PM
|
